Predictive Oncology Files 8-K on Financials
Ticker: AGPU · Form: 8-K · Filed: May 15, 2025 · CIK: 1446159
Sentiment: neutral
Topics: financial-reporting, company-update
TL;DR
Predictive Oncology dropped an 8-K on May 15th detailing financials. Check it out.
AI Summary
Predictive Oncology Inc. filed an 8-K on May 15, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits. The company was formerly known as Skyline Medical Inc. and Precision Therapeutics Inc.
Why It Matters
This filing provides an update on the company's financial status and operational results, which is crucial for investors to assess its current performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Predictive Oncology Inc. (company) — Registrant
- May 15, 2025 (date) — Date of earliest event reported
- Skyline Medical Inc. (company) — Former company name
- Precision Therapeutics Inc. (company) — Former company name
FAQ
What specific financial information is being reported in this 8-K?
The 8-K states it is reporting on 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K filing submitted?
The filing was submitted on May 15, 2025.
What were Predictive Oncology Inc.'s previous names?
Predictive Oncology Inc. was formerly known as Precision Therapeutics Inc. and Skyline Medical Inc.
What is the company's primary business as indicated by its SIC code?
The company's Standard Industrial Classification (SIC) code is 3842, which relates to 'ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES'.
Where is Predictive Oncology Inc. headquartered?
The company's business address is 91 43RD STREET, SUITE 110, PITTSBURGH, PA 15201.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 15, 2025 regarding Predictive Oncology Inc. (AGPU).